Agilon Health (AGL)
(Delayed Data from NYSE)
$0.95 USD
-0.07 (-7.20%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $0.94 -0.01 (-0.70%) 7:58 PM ET
5-Strong Sell of 5 5
F Value A Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AGL 0.95 -0.07(-7.20%)
Will AGL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGL
New Strong Sell Stocks for October 8th
New Strong Sell Stocks for October 1st
AGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for August 20th
Here's What Key Metrics Tell Us About Agilon (AGL) Q2 Earnings
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
Other News for AGL
Is AGL gaining bearish strength? 180 Bearish Setup shows up after plummeting 6.42%
AGL forms Pocket Pivot on October 8
Evercore ISI Sticks to Its Hold Rating for Agilon Health (AGL)
AGL Fell Below 20 Day Moving Average on October 7
ANGLE plc Announces Strategic Shift and Name Change to CelLBxHealth